Cisplatin

Once-a-Week Versus Once-Every-3-Weeks Cisplatin Along With Radiation in Head and Neck Cancer

European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn:

“Long-Term Update of a Phase 3 Randomized Study Comparing Once-a-Week Versus Once-Every-3-Weeks Cisplatin Along With Radiation in Head and Neck Cancer, published in the Red Journal.

Read it before your patients.”

Cisplatin

Source: ESTRO/LinkedIn

cancer Cisplatin ESTRO European SocieTy for Radiotherapy and Oncology Head and Neck Cancer OncoDaily Oncology Red Journal